Factors Influencing the Subjective Sexual Function in Patients with Schizophrenia Switched to Olanzapine.
- Author:
Hyun Jeong LEE
1
;
Hyeri YOON
;
S H Samuel HWANG
;
Se Hyun KIM
;
Dong Chung JUNG
;
Nam Young LEE
;
Yong Sik KIM
;
Yong Min AHN
Author Information
1. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea. aym@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Sexual dysfunction;
Prolactin;
Extrapyramidal symptom;
Olanzapine;
LUNSERS
- MeSH:
Antipsychotic Agents;
Benzodiazepines;
Dyskinesias;
Humans;
Hypersensitivity;
International Classification of Diseases;
Phenothiazines;
Prolactin;
Psychomotor Agitation;
Quality of Life;
Schizophrenia;
Vital Signs
- From:Korean Journal of Psychopharmacology
2011;22(2):80-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Sexual dysfunction is highly prevalent in both untreated and treated patients with schizophrenia. Sexual dysfunction is a major cause of poor quality of life, negative attitude to therapy and treatment non-compliance. We thereby conducted this study to better understand the predictors of subjective sexual dysfunction. METHODS: The subjects consisted of 83 patients (46 men; 37 women) who participated in an open label study on switching antipsychotics to olanzapine. All subjects met the Tenth Revision of International Classification of Diseases diagnostic criteria for schizophrenia. To better understand the predictors of subjective sexual dysfunction, we used the Liverpool University Neuroleptic Side-effect Rating scale (LUNSERS), a comprehensive self-rating instrument for assessing and quantifying the subjective adverse events during antipsychotic treatment. All patients were taking antipsychotics at the initiation of the study and were assessed using LUNSERS, the Simpson-Angus Scale (SAS), the Barnes Akathisia Rating scale (BARS), Abnormal Involuntary Movement Scale (AIMS), Clinical Global Impression (CGI), and the Positive and Negative Syndrome Scale (PANSS). They were also checked for their serum prolactin levels and vital signs before and after a 6-week treatment with olanzapine. In order to identify the cross-sectional and longitudinal predictors of LUNSERS hormonal side effect, we carried out multiple regression analyses. RESULTS: Prolactin levels, LUNSERS hormonal side effect, CGI, PANSS, SAS, AIMS, and BARS decreased after a 6-week treatment with olanzapine. At initial evaluation, cross-sectional predictors of LUNSERS hormonal side effect were red herring and allergic reaction subscale, but after the 6-week treatment with olanzapine, none of the variables were found to significantly predict LUNSERS hormonal side effect. Longitudinal predictors of LUNSERS hormonal side effect were LUNSERS extrapyramidal system side effect and prolactin levels. CONCLUSION: These findings suggested relationships among prolactin, extrapyramidal symptom, motor function and sexual dysfunction. After switching to olanzapine, sexual function of the patients improved subjectively. More studies are warranted as these results have significant implications for quality of life and treatment adherence.
